|
US4684620A
(en)
|
1984-09-04 |
1987-08-04 |
Gibson-Stephens Neuropharmaceuticals, Inc. |
Cyclic polypeptides having mu-receptor specificity
|
|
US4724229A
(en)
|
1986-09-30 |
1988-02-09 |
Smithkline Beckman Corporation |
Arg-arg-arg-vasopressin antagonists
|
|
JPH02306947A
(ja)
|
1989-05-01 |
1990-12-20 |
Monsanto Co |
キラルβ―アミノ酸の製造方法
|
|
US5192746A
(en)
|
1990-07-09 |
1993-03-09 |
Tanabe Seiyaku Co., Ltd. |
Cyclic cell adhesion modulation compounds
|
|
CA2106314A1
(en)
|
1991-04-05 |
1992-10-06 |
John P. Burnier |
Platelet aggregation inhibitors having high specification for gpiibiiia
|
|
US5569741A
(en)
|
1992-07-27 |
1996-10-29 |
Biomeasure, Inc. |
Cyclic octapeptide neuromedin B receptor antagonists
|
|
EP0644772B1
(en)
|
1992-11-12 |
2003-04-02 |
Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. |
Opioid peptides
|
|
US5293050A
(en)
|
1993-03-25 |
1994-03-08 |
International Business Machines Corporation |
Semiconductor quantum dot light emitting/detecting devices
|
|
AU673731B2
(en)
|
1993-06-03 |
1996-11-21 |
Banyu Pharmaceutical Co., Ltd. |
Novel endothelin antagonistic peptide
|
|
GB9516994D0
(en)
|
1995-08-18 |
1995-10-18 |
Iaf Biochem Int |
Solution synthesis of peripheral acting analgestic opioid tetrapeptides
|
|
US6037324A
(en)
|
1996-01-04 |
2000-03-14 |
Leukosite, Inc. |
Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor
|
|
US5990084A
(en)
|
1996-04-19 |
1999-11-23 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
GB9613112D0
(en)
|
1996-06-21 |
1996-08-28 |
Zeneca Ltd |
Chemical compounds
|
|
US7122623B2
(en)
|
1996-07-12 |
2006-10-17 |
Adherex Technologies, Inc. |
Compounds and methods for modulating cell adhesion
|
|
JP3149958B2
(ja)
|
1996-08-30 |
2001-03-26 |
ノボ ノルディスク アクティーゼルスカブ |
Ｇｌｐ―１誘導体
|
|
US5942492A
(en)
|
1996-11-12 |
1999-08-24 |
Angstrom Pharmaceuticals, Inc. |
Cyclic peptides that bind to urokinase-type plasminogen activator receptor
|
|
US5993811A
(en)
|
1997-02-03 |
1999-11-30 |
Biology Associates, Llc |
Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
|
|
JP2001509493A
(ja)
|
1997-07-11 |
2001-07-24 |
インナーダイン， インコーポレイテッド |
放射送達構造体の調製およびシール化のための方法およびシステム
|
|
US6818617B1
(en)
|
1997-08-15 |
2004-11-16 |
Temple University- Of The Commonwealth System Of Higher Education |
EC-3, an inhibitor of α4β1 and α4β7 integrins
|
|
US6271252B1
(en)
|
1997-11-24 |
2001-08-07 |
Merck & Co., Inc. |
Cyclic amino acid derivatives as cell adhesion inhibitors
|
|
US8038984B2
(en)
|
1998-06-20 |
2011-10-18 |
Washington University |
Membrane-permeant peptide complexes for treatment of sepsis
|
|
EP1100473A2
(en)
|
1998-07-28 |
2001-05-23 |
InnerDyne, Inc. |
Absorbable brachytherapy and chemotherapy delivery devices and methods
|
|
EP1105427A2
(en)
|
1998-08-17 |
2001-06-13 |
Abgenix, Inc. |
Generation of modified molecules with increased serum half-lives
|
|
US6087334A
(en)
|
1998-08-21 |
2000-07-11 |
Amylin Pharmaceuticals, Inc. |
Anti-diabetic peptides
|
|
AUPP616498A0
(en)
|
1998-09-25 |
1998-10-15 |
University Of Queensland, The |
Synthesis of cyclic peptides
|
|
AUPP616598A0
(en)
|
1998-09-25 |
1998-10-15 |
University Of Queensland, The |
Auxiliary for amide bond formation
|
|
AUPP660698A0
(en)
|
1998-10-21 |
1998-11-12 |
University Of Queensland, The |
A method of protein engineering
|
|
US6451987B1
(en)
|
1999-03-15 |
2002-09-17 |
Novo Nordisk A/S |
Ion exchange chromatography of proteins and peptides
|
|
HUP0200297A3
(en)
|
1999-03-17 |
2002-09-30 |
Novo Nordisk As |
Method for acylating peptides and the glutaminic acid derivatives as acylating agents
|
|
EE200100528A
(et)
|
1999-04-12 |
2003-02-17 |
Aventis Pharma Limited |
Asendatud bitsükliline heteroarüülühend, seda sisaldav farmatseutiline kompositsioon ning nende raviotstarbeline kasutamine
|
|
AU2001262089A1
(en)
|
2000-03-14 |
2001-09-24 |
Novartis Ag |
Alpha4beta1 and alpha4beta7 integrin inhibitors
|
|
US20110131679A2
(en)
|
2000-04-19 |
2011-06-02 |
Thomas La Rosa |
Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
|
|
KR20030068205A
(ko)
|
2001-01-09 |
2003-08-19 |
메르크 파텐트 게엠베하 |
수용체 타이로신 키나아제 저해제 및 혈관형성 저해제를사용하는 병용 요법
|
|
DE10107707A1
(de)
|
2001-02-19 |
2002-08-29 |
Wilex Biotechnology Gmbh |
Antagonisten für alpha¶4¶beta¶7¶-Integrin
|
|
EP1451211A2
(en)
|
2001-03-30 |
2004-09-01 |
University of Copenhagen |
Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease
|
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
|
AUPS039702A0
(en)
|
2002-02-08 |
2002-03-07 |
University Of Queensland, The |
Common protein surface shapes and uses therefor
|
|
US20030166138A1
(en)
|
2002-02-21 |
2003-09-04 |
Todd Kinsella |
Cyclic peptides and analogs useful to treat allergies
|
|
CA2484941A1
(en)
|
2002-07-24 |
2004-02-05 |
Intercell Ag |
Antigens encoded by alternative reading frame from pathogenic viruses
|
|
US20040176293A1
(en)
|
2002-12-18 |
2004-09-09 |
Wyeth |
Methods for screening, treating and diagnosing inflammatory bowel disease and compositions thereof
|
|
WO2004058804A1
(en)
|
2002-12-24 |
2004-07-15 |
Walter And Eliza Hall Institute Of Medical Research |
Peptides and therapeutic uses thereof
|
|
US20070166711A1
(en)
|
2003-04-15 |
2007-07-19 |
Samuels Mark E |
Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof
|
|
WO2005044839A2
(en)
|
2003-11-05 |
2005-05-19 |
Dana-Farber Cancer Institute, Inc. |
Stabilized alpha helical peptides and uses thereof
|
|
WO2005064345A2
(en)
*
|
2003-12-19 |
2005-07-14 |
Applera Corporation |
Methods and systems for protein and peptide evidence assembly
|
|
MX370489B
(es)
|
2004-01-09 |
2019-12-16 |
Pfizer |
Anticuerpos contra madcam.
|
|
US8536140B2
(en)
|
2004-03-12 |
2013-09-17 |
Mti Meta Tech Inc. |
Methods for treating inflammatory bowel disease
|
|
NZ551934A
(en)
|
2004-06-24 |
2009-09-25 |
Inst Medical W & E Hall |
Conjugates comprising a targeting moiety and a peptide that mimics the apoptosis-inducing BH3-only proteins
|
|
NZ554331A
(en)
|
2004-09-23 |
2009-04-30 |
Univ Melbourne |
Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection
|
|
WO2006062685A2
(en)
|
2004-11-11 |
2006-06-15 |
Affymax, Inc. |
Novel peptides that bind to the erythropoietin receptor
|
|
JP2008521840A
(ja)
|
2004-11-30 |
2008-06-26 |
ガストロテック・ファルマ・アクティーゼルスカブ |
成長ホルモン分泌促進物質レセプター１ａリガンド
|
|
NZ555926A
(en)
|
2004-12-20 |
2008-11-28 |
Antibodyshop As |
Determination of neutrophil gelatinase-associated lipocalin (NGAL) as a diagnostic marker for renal disorders
|
|
US20100183617A1
(en)
|
2005-02-23 |
2010-07-22 |
University Of Virginia Patent Foundation |
Compositions and methods for regulating sas1r
|
|
US7534764B2
(en)
|
2005-06-29 |
2009-05-19 |
The Regents Of The University Of California |
Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin
|
|
WO2007038619A2
(en)
|
2005-09-27 |
2007-04-05 |
Amunix, Inc. |
Proteinaceous pharmaceuticals and uses thereof
|
|
US8076306B2
(en)
|
2006-04-12 |
2011-12-13 |
Isis Pharmaceuticals, Inc. |
Compositions and their uses directed to hepcidin
|
|
BRPI0713098A2
(pt)
|
2006-05-22 |
2012-10-16 |
Clinical Genomics Pty Ltd |
método para determinar a origem anatÈmica de uma célula ou população celular derivada do intestino grosso de um indivìduo, método de detecção para determinar a origem anatÈmica de uma célula ou população celular derivada do intestino grosso de um indivìduo, sistema de detecção, meio de armazenagem legìvel por computador, arranjo de ácido nucleico, uso de um arranjo, método para determinar o inìcio ou predisposição para o inìcio de uma anormalidade celular ou uma condição destinguida por uma anormalidade celular no intestino grosso, kit de diagnóstico para ensaiar amostras biológicas
|
|
GB0610395D0
(en)
|
2006-05-25 |
2006-07-05 |
Ge Healthcare Ltd |
Novel imaging agents
|
|
WO2007147019A2
(en)
|
2006-06-13 |
2007-12-21 |
Zymogenetics, Inc. |
Il-17 and il-23 antagonists and methods of using the same
|
|
US20080019913A1
(en)
|
2006-07-07 |
2008-01-24 |
University Of Arizona Office Of Technology Transfer |
Enkepahlin analogs with improved bioavailability
|
|
WO2008045252A2
(en)
|
2006-10-04 |
2008-04-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Engineered integrin binding peptides
|
|
US7713937B2
(en)
|
2006-11-10 |
2010-05-11 |
Cara Therapeutics, Inc. |
Synthetic peptide amides and dimeric forms thereof
|
|
US9193790B2
(en)
|
2006-12-07 |
2015-11-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of antagonists of the interaction between HIV GP120 and A4B7 integrin
|
|
AR065083A1
(es)
|
2007-02-02 |
2009-05-13 |
Amgen Inc |
Hepcidina, antagonistas de la hepcidina y metodos de uso
|
|
MX2009008241A
(es)
|
2007-02-15 |
2009-10-08 |
Univ Indiana Res & Tech Corp |
Co-agonistas de receptor de glucagon/glp-1.
|
|
DK2426144T3
(da)
|
2007-02-23 |
2019-01-07 |
Merck Sharp & Dohme |
Manipulerede Anti-IL-23P19-antistoffer
|
|
US20080260820A1
(en)
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
|
ES2465223T3
(es)
|
2007-04-27 |
2014-06-05 |
Zymogenetics, Inc. |
Antagonistas de IL-17A, IL-17F e IL-23P19 y procedimientos de uso
|
|
US8313950B2
(en)
*
|
2007-05-21 |
2012-11-20 |
The Ohio State University Research Foundation |
Hepcidins as biomarkers for impending lupus nephritis flare
|
|
US20090131317A1
(en)
|
2007-06-22 |
2009-05-21 |
Affymax, Inc. |
Compounds and peptides that bind the trail receptor
|
|
JP2011501941A
(ja)
|
2007-07-06 |
2011-01-20 |
バロリゼイション エイチエスジェイ， ソシエテ アン コマンディテ |
Ｉｌ−２３レセプターのアンタゴニストおよびその使用
|
|
CN101358201A
(zh)
|
2007-07-31 |
2009-02-04 |
钱忠明 |
重组人铁调素腺病毒、其制备方法及应用
|
|
CN101307085B
(zh)
|
2007-08-01 |
2012-06-13 |
香港理工大学深圳研究院 |
抑制铁调素调节蛋白的siRNA、重组慢病毒及其应用
|
|
CA2707840A1
(en)
|
2007-08-20 |
2009-02-26 |
Allozyne, Inc. |
Amino acid substituted molecules
|
|
GR1006896B
(el)
*
|
2007-08-24 |
2010-07-20 |
Ελληνικο Ινστιτουτο Παστερ, |
Μεθοδος παραγωγης μιας πεπτιδικης ορμονης
|
|
WO2009039185A1
(en)
|
2007-09-17 |
2009-03-26 |
The Trustees Of Columbia University In The City Of New York |
Uses of immunologically modified scaffold for tissue prevascularization and cell transplantation
|
|
WO2009045536A2
(en)
|
2007-10-05 |
2009-04-09 |
The University Of North Carolina At Chapel Hill |
Receptor targeted oligonucleotides
|
|
WO2010062663A1
(en)
|
2008-11-03 |
2010-06-03 |
Schering Corporation |
Inflammatory bowel disease biomarkers and related methods of treatment
|
|
WO2010065815A2
(en)
*
|
2008-12-05 |
2010-06-10 |
The Regents Of The University Of California |
Mini-hepcidin peptides and methods of using thereof
|
|
DE102009007381A1
(de)
|
2009-01-29 |
2010-08-05 |
Amp-Therapeutics Gmbh & Co. Kg |
Antibiotische Peptide
|
|
US8999935B2
(en)
|
2009-02-11 |
2015-04-07 |
New York University |
Treatment of osteoporosis in peri- and post-menopausal women with hepcidin
|
|
CN102459311B
(zh)
|
2009-04-08 |
2015-08-19 |
武田药品工业株式会社 |
神经调节肽u衍生物
|
|
TWI578992B
(zh)
*
|
2009-04-30 |
2017-04-21 |
諾克森製藥股份有限公司 |
與鐵調節激素（ｈｅｐｃｉｄｉｎ）結合之核酸類
|
|
US20110142889A1
(en)
|
2009-12-16 |
2011-06-16 |
Nod Pharmaceuticals, Inc. |
Compositions and methods for oral drug delivery
|
|
WO2011091357A1
(en)
|
2010-01-25 |
2011-07-28 |
Cornell University |
Aromatic-cationic peptides and uses of same
|
|
US10416172B2
(en)
|
2010-03-31 |
2019-09-17 |
Medical Diagnostic Laboratories, Llc |
Recombinant soluble truncated IL-23 receptor (IL-23R) capable of inhibiting IL-23R-mediated cell signaling
|
|
JP2011231085A
(ja)
|
2010-04-30 |
2011-11-17 |
Osaka Prefecture Univ |
環状ペプチド
|
|
US20130236977A1
(en)
*
|
2010-05-24 |
2013-09-12 |
Children's Medical Center Corporation |
Compositions and methods for plasma peptide analysis
|
|
IT1406051B1
(it)
|
2010-08-05 |
2014-02-06 |
D M G Italia S R L |
Uso di hmgb1 come marcatore biologico di infiammazione intestinale umana, metodo non invasivo per la sua rilevazione in campioni fecali e kit relativo.
|
|
HRP20192207T1
(hr)
|
2010-08-11 |
2020-02-21 |
Ironwood Pharmaceuticals, Inc. |
Stabilne formulacije linaklotida
|
|
EP2444101A1
(en)
|
2010-10-21 |
2012-04-25 |
Universitätsklinikum Freiburg |
Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis
|
|
EP2668199B1
(en)
|
2011-01-27 |
2017-09-06 |
Ramot at Tel Aviv University, Ltd. |
Glycogen synthase kinase-3 inhibitors
|
|
US8946150B2
(en)
|
2011-06-14 |
2015-02-03 |
Medical Diagnostic Laboratories, LLC. |
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
|
|
CN103764159A
(zh)
|
2011-06-14 |
2014-04-30 |
康肽德生物医药技术有限公司 |
芳香族阳离子肽及其用途
|
|
US9605027B2
(en)
|
2011-06-14 |
2017-03-28 |
Medical Diagnostic Laboratories, Llc |
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
|
|
US9169292B2
(en)
|
2011-06-14 |
2015-10-27 |
Medical Diagnostic Laboratories, Llc |
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
|
|
BR112014013697A2
(pt)
|
2011-12-09 |
2020-11-03 |
The Regents Of The University Of California |
peptídeos mini-hepcidina modificados e métodos de uso dos mesmos
|
|
EP2850095B1
(en)
|
2012-05-17 |
2019-10-09 |
RA Pharmaceuticals, Inc. |
Peptide and peptidomimetic inhibitors
|
|
WO2013177432A1
(en)
|
2012-05-23 |
2013-11-28 |
The University Of Chicago |
Methods of treating obesity
|
|
US9024044B2
(en)
|
2012-06-14 |
2015-05-05 |
Ajinomoto Co., Inc. |
Heteroarylcarboxylic acid ester derivative
|
|
US9273093B2
(en)
|
2012-10-11 |
2016-03-01 |
Protagonist Therapeutics, Inc. |
α4β7 peptide dimer antagonists
|
|
CA2901436A1
(en)
|
2013-02-15 |
2014-08-21 |
Srx Cardio, Llc |
Proprotein convertase subtilisin/kexin type 9 (pcsk9) allosteric binding ligands to modulate serum low density lipoprotein (ldl) levels
|
|
KR102236829B1
(ko)
|
2013-03-15 |
2021-04-07 |
프로타고니스트 테라퓨틱스, 인코포레이티드 |
헵시딘 유사체 및 이의 용도
|
|
US20140294902A1
(en)
|
2013-04-02 |
2014-10-02 |
Protagonist Therapeutics, Inc. |
Novel a4b7 peptide antagonists
|
|
US20140294901A1
(en)
|
2013-04-02 |
2014-10-02 |
Protagonist Therapeutics, Inc. |
Novel a4b7 peptide dimer antagonists
|
|
AU2014300713B2
(en)
|
2013-06-24 |
2019-02-14 |
Canbas Co., Ltd. |
Peptides and peptidomimetics in combination uses and treatments for cancer patient subpopulations
|
|
CA2916492A1
(en)
|
2013-06-27 |
2014-12-31 |
Stealth Biotherapeutics Corp |
Peptide therapeutics and methods for using same
|
|
AU2014331812B2
(en)
|
2013-10-09 |
2019-01-17 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for downregulation of pro-inflammatory cytokines
|
|
WO2015112700A1
(en)
|
2014-01-22 |
2015-07-30 |
Wisconsin Alumni Research Foundation |
Alpha/beta-peptide mimics of z-domain peptides
|
|
AU2015243990A1
(en)
|
2014-04-07 |
2016-11-10 |
La Jolla Pharmaceutical Company |
Hepcidin mimetic peptides and uses thereof
|
|
AU2015258863B2
(en)
|
2014-05-16 |
2019-10-24 |
Protagonist Therapeutics, Inc. |
Alpha4beta7 integrin thioether peptide antagonists
|
|
WO2015183963A2
(en)
|
2014-05-28 |
2015-12-03 |
Stealth Peptides International, Inc. |
Therapeutic compositions including redox-active parabenzoquinones and uses thereof
|
|
WO2015200916A2
(en)
|
2014-06-27 |
2015-12-30 |
Protagonist Therapeutics, Inc. |
Hepcidin and mini-hepcidin analogues and uses therof
|
|
WO2016004093A2
(en)
|
2014-07-01 |
2016-01-07 |
Stealth Biotherapeutics Corp |
Therapeutic compositions including galectin-3 inhibitors and uses thereof
|
|
AU2015289642B2
(en)
|
2014-07-17 |
2021-02-25 |
Protagonist Therapeutics, Inc. |
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
|
|
EP3201217A4
(en)
|
2014-10-01 |
2018-07-18 |
Protagonist Therapeutics Inc. |
Novel cyclic monomer and dimer peptides having integrin antagonist activity
|
|
WO2016054411A1
(en)
|
2014-10-01 |
2016-04-07 |
Protagonist Therapeutics, Inc. |
NOVEL α4β7 PEPTIDE MONOMER AND DIMER ANTAGONISTS
|
|
WO2016109363A1
(en)
|
2014-12-29 |
2016-07-07 |
The Regents Of The University Of California |
S-Alkylated Hepcidin Peptides and Methods of Making and Using Thereof
|
|
US20160199437A1
(en)
|
2015-01-08 |
2016-07-14 |
D. Travis Wilson |
Therapeutic compositions including iron chelators and uses thereof
|
|
WO2016115168A1
(en)
|
2015-01-12 |
2016-07-21 |
Synthorx, Inc. |
Incorporation of unnatural nucleotides and methods thereof
|
|
US20160228491A1
(en)
|
2015-02-09 |
2016-08-11 |
Stealth Biotherapeutics Corp |
Therapeutic compositions including phenazine-3-one and phenothiazine-3-one derivatives and uses thereof
|
|
WO2016195663A1
(en)
|
2015-06-02 |
2016-12-08 |
Stealth Peptides International, Inc. |
Therapeutic compositions including bpm 31510, variants and analogues thereof, and uses thereof
|
|
WO2016200364A1
(en)
|
2015-06-08 |
2016-12-15 |
Stealth Peptides International, Inc. |
THERAPEUTIC COMPOSITIONS INCLUDING SkQ COMPOUNDS AND USES THEREOF
|
|
US10787490B2
(en)
|
2015-07-15 |
2020-09-29 |
Protaganist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
UA123772C2
(uk)
|
2015-07-15 |
2021-06-02 |
Протагоніст Терепьютікс, Інк. |
Пептидний інгібітор рецептора інтерлейкіну-23 та спосіб лікування запального захворювання кишечнику (ibd)
|
|
SG10202005377VA
(en)
|
2015-10-23 |
2020-07-29 |
Vifor Int Ag |
Novel ferroportin inhibitors
|
|
WO2017117411A1
(en)
|
2015-12-30 |
2017-07-06 |
Protagonist Therapeutics, Inc. |
Analogues of hepcidin mimetics with improved in vivo half lives
|
|
EP3432906A4
(en)
|
2016-03-23 |
2020-04-01 |
Protagonist Therapeutics, Inc. |
METHOD FOR SYNTHETIZING ALPHA4BETA7 PEPTIDE ANTAGONISTS
|
|
WO2018022917A1
(en)
|
2016-07-27 |
2018-02-01 |
Protagonist Therapeutics, Inc. |
Disulfide-rich peptide libraries and methods of use thereof
|
|
WO2018022937A1
(en)
|
2016-07-27 |
2018-02-01 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases
|
|
AU2017324446A1
(en)
|
2016-09-06 |
2019-03-28 |
La Jolla Pharmceutical Company |
Methods of treating iron overload
|
|
WO2018089693A2
(en)
|
2016-11-09 |
2018-05-17 |
Protagonist Therapeutics, Inc. |
Methods for determining and monitoring gastrointestinal inflammation
|
|
EP3551642B1
(en)
|
2016-12-06 |
2025-02-26 |
Universiteit van Amsterdam |
Multicyclic peptides and methods for their preparation
|
|
WO2018128828A1
(en)
|
2016-12-23 |
2018-07-12 |
Bayer Healthcare Llc |
Novel hepcidin mimetics and uses thereof
|
|
EP3570864B1
(en)
|
2017-01-18 |
2026-02-18 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
US10278957B2
(en)
|
2017-09-11 |
2019-05-07 |
Protagonist Therapeutics, Inc. |
Opioid agonist peptides and uses thereof
|
|
EP3749345A4
(en)
|
2018-02-08 |
2022-04-06 |
Protagonist Therapeutics, Inc. |
CONJUGATED HEPCIDIN MIMETICS
|
|
US12171764B2
(en)
|
2018-06-20 |
2024-12-24 |
Biora Therapeutics, Inc. |
Treatment of a disease of the gastrointestinal tract with a JAK or other kinase inhibitor
|
|
IL321719A
(en)
|
2018-06-21 |
2025-08-01 |
Merck Sharp ַ& Dohme Llc |
Pcsk9 antagonist compounds
|
|
TW202019948A
(zh)
|
2018-07-12 |
2020-06-01 |
美商領導醫療有限公司 |
介白素-23受體之肽抑制劑及其治療發炎疾病之用途
|
|
CA3135024A1
(en)
|
2019-03-28 |
2020-10-01 |
Protagonist Therapeutics, Inc. |
Methods for synthesizing .beta.-homoamino acids
|
|
MX2022000397A
(es)
|
2019-07-10 |
2022-04-25 |
Protagonist Therapeutics Inc |
Inhibidores peptídicos del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias.
|
|
TW202116793A
(zh)
|
2019-07-10 |
2021-05-01 |
美商領導醫療有限公司 |
介白素-23受體之肽抑制劑及其於治療發炎疾病的用途
|
|
EP4025592B1
(en)
|
2019-09-03 |
2025-10-29 |
Protagonist Therapeutics, Inc. |
Conjugated hepcidin mimetics for use in treating of polycythemia vera
|
|
KR20220125268A
(ko)
|
2020-01-10 |
2022-09-14 |
프로타고니스트 테라퓨틱스, 인코포레이티드 |
α4β7 인테그린 길항제를 사용한 염증성 장 질환의 치료 방법
|
|
CN118063554A
(zh)
|
2020-01-15 |
2024-05-24 |
詹森生物科技公司 |
介白素-23受体的肽抑制剂及其治疗炎性疾病的用途
|
|
KR20220141808A
(ko)
|
2020-01-15 |
2022-10-20 |
얀센 바이오테크 인코포레이티드 |
인터루킨-23 수용체의 펩티드 억제제 및 염증성 질환을 치료하기 위한 이의 용도
|
|
US20230129095A1
(en)
|
2020-01-15 |
2023-04-27 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
|
KR20230053615A
(ko)
|
2020-07-28 |
2023-04-21 |
프로타고니스트 테라퓨틱스, 인코포레이티드 |
접합된 헵시딘 모방체
|
|
KR20230110570A
(ko)
|
2020-11-20 |
2023-07-24 |
얀센 파마슈티카 엔.브이. |
인터류킨-23 수용체의 펩티드 억제제의 조성물
|
|
WO2022212696A1
(en)
|
2021-04-01 |
2022-10-06 |
Protagonist Therapeutics, Inc. |
Conjugated hepcidin mimetics
|
|
US20240226225A1
(en)
|
2021-04-01 |
2024-07-11 |
Protagonist Therapeutics, Inc. |
Conjugated hepcidin mimetics
|
|
WO2022212700A2
(en)
|
2021-04-01 |
2022-10-06 |
Protagonist Therapeutics, Inc. |
Conjugated hepcidin mimetics
|
|
WO2022266060A1
(en)
|
2021-06-14 |
2022-12-22 |
Protagonist Therapeutics, Inc. |
Hepcidin mimetics for treatment of hereditary hemochromatosis
|
|
TW202330013A
(zh)
|
2021-07-14 |
2023-08-01 |
美商健生生物科技公司 |
介白素－２３受體之脂化肽抑制劑
|
|
AU2022310354A1
(en)
|
2021-07-14 |
2024-02-29 |
Janssen Biotech, Inc. |
Peptide inhibitors of interleukin-23 receptor
|
|
EP4370532A4
(en)
|
2021-07-14 |
2025-09-03 |
Janssen Biotech Inc |
BICYCLIC PEPTIDE INHIBITORS OF THE INTERLEUKIN-23 RECEPTOR
|
|
EP4376887A4
(en)
|
2021-07-30 |
2025-09-24 |
Janssen Biotech Inc |
MATERIALS AND METHODS FOR MAKING OR USING IL-23 R BINDING PROTEINS
|
|
US20250170216A1
(en)
|
2022-02-02 |
2025-05-29 |
Protagonist Therapeutics, Inc. |
Conjugated hepcidin mimetics
|
|
EP4472995A4
(en)
|
2022-02-02 |
2025-11-19 |
Protagonist Therapeutics Inc |
Conjugated hepcidin mimetics
|
|
US20250360187A1
(en)
|
2022-06-07 |
2025-11-27 |
Protagonist Therapeutics, Inc. |
Hepcidin mimetics for treatment of sickle cell disease
|
|
WO2024011188A1
(en)
|
2022-07-07 |
2024-01-11 |
Protagonist Therapeutics, Inc. |
Combination therapy for treatment of iron overload diseases
|